Zobrazeno 1 - 10
of 69
pro vyhledávání: '"Katri Koli"'
Autor:
Jaana Kaunisto, Eija-Riitta Salomaa, Ulla Hodgson, Riitta Kaarteenaho, Hannu Kankaanranta, Katri Koli, Tero Vahlberg, Marjukka Myllärniemi
Publikováno v:
ERJ Open Research, Vol 5, Iss 3 (2019)
Idiopathic pulmonary fibrosis (IPF) is characterised by unpredictable disease course and poor survival. After the introduction of novel antifibrotic drugs, the prognosis of patients with IPF is probably changing. FinnishIPF, a nationwide registry of
Externí odkaz:
https://doaj.org/article/7c5a7c66c58143ce821d8e953509d963
Autor:
Insa Bultmann-Mellin, Anne Conradi, Alexandra C. Maul, Katharina Dinger, Frank Wempe, Alexander P. Wohl, Thomas Imhof, F. Thomas Wunderlich, Alexander C. Bunck, Tomoyuki Nakamura, Katri Koli, Wilhelm Bloch, Alexander Ghanem, Andrea Heinz, Harald von Melchner, Gerhard Sengle, Anja Sterner-Kock
Publikováno v:
Disease Models & Mechanisms, Vol 8, Iss 4, Pp 403-415 (2015)
Recent studies have revealed an important role for LTBP-4 in elastogenesis. Its mutational inactivation in humans causes autosomal recessive cutis laxa type 1C (ARCL1C), which is a severe disorder caused by defects of the elastic fiber network. Altho
Externí odkaz:
https://doaj.org/article/a4bd9f218f2d4e76a01d420ae7b52376
Autor:
Katri Koli, Eva Sutinen, Mikko Rönty, Pia Rantakari, Vittorio Fortino, Ville Pulkkinen, Dario Greco, Petra Sipilä, Marjukka Myllärniemi
Publikováno v:
PLoS ONE, Vol 11, Iss 7, p e0159010 (2016)
Idiopathic pulmonary fibrosis (IPF) is characterized by activation and injury of epithelial cells, the accumulation of connective tissue and changes in the inflammatory microenvironment. The bone morphogenetic protein (BMP) inhibitor protein gremlin-
Externí odkaz:
https://doaj.org/article/147975475bf9491c8362870b8ed4e155
Autor:
Eva Sutinen, Henrik Wolff, Jari Räsänen, Tapio Vehmas, Katri Koli, Eeva Kuosma, Sanna Laaksonen, Jarmo A. Salo, Kirsti Husgafvel-Pursiainen, Ilkka Ilonen, Marjukka Myllärniemi
Publikováno v:
Acta Oncologica. 58:38-44
Background: Malignant pleural mesothelioma (MPM) is a rare occupational cancer with a poor prognosis. Even with a multimodality treatment approach, the treatment outcomes remain unsatisfactory. The use of asbestos has been banned in most developed co
Autor:
Mayank Saraswat, Katri Koli, Eva Sutinen, Risto Renkonen, Ville Vartiainen, Tiialotta Tohmola, Sakari Joenväärä, Marjukka Myllärniemi
Publikováno v:
Scientific Reports
Scientific Reports, Vol 10, Iss 1, Pp 1-11 (2020)
Scientific Reports, Vol 10, Iss 1, Pp 1-11 (2020)
Idiopathic pulmonary fibrosis (IPF) is a lung parenchymal disease of unknown cause usually occurring in older adults. It is a chronic and progressive condition with poor prognosis and diagnosis is largely clinical. Currently, there exist few biomarke
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::29b996f2c5dcb8f759df60cdde4923f3
http://hdl.handle.net/10138/319352
http://hdl.handle.net/10138/319352
Autor:
Janne Raula, Ville Vartiainen, Nurcin Ugur, Luis M. Bimbo, Jenni Viinamäki, Marjukka Myllärniemi, Katri Koli, Esko I. Kauppinen, Eva Sutinen, Janne T. Backman, Emmi I. Joensuu
Publikováno v:
INTERNATIONAL JOURNAL OF PHARMACEUTICS. 544(1):121-128
The aim of this work was to study the antifibrotic effect of pulmonary administration of tilorone to lung fibrosis. L-leucine coated tilorone particles were prepared and their aerosolization properties were analyzed using two dry powder inhalers (Eas
Autor:
Mira Tissari, Irene Ylivinkka, Katri Koli, Pernilla von Nandelstadh, Mikko Rönty, Miao Yin, Kaisa Lehti, Jenni A. Tamminen, Marko Hyytiäinen, Marjukka Myllärniemi
Publikováno v:
Oncotarget
// Miao Yin 1, 2 , Mira Tissari 1, 2 , Jenni Tamminen 1, 2 , Irene Ylivinkka 1 , Mikko Ronty 3 , Pernilla von Nandelstadh 4 , Kaisa Lehti 4, 5, 6 , Marko Hyytiainen 4 , Marjukka Myllarniemi 7 and Katri Koli 1, 2 1 Research Programs Unit, Translationa
Autor:
Norbert Weissmann, Susan Scheibe, Katri Koli, Harald von Melchner, Martin Serchinger, Ana Tomasovic, Silke De-Zolt, Duran Sürün, Anja Sterner-Kock, Nina Kurrle, Frank Schnütgen, Frank Wempe
Publikováno v:
Matrix Biology. 59:109-120
Latent transforming growth factor beta binding protein 4 (LTBP4) belongs to the fibrillin/LTBP family of proteins and plays an important role as a structural component of extracellular matrix (ECM) and local regulator of TGF beta signaling. We have p
Autor:
Eeva Rouvinen, Marjukka Myllärniemi, Katri Koli, Helena Lauri, Jari Räsänen, Eva Sutinen, Ilkka Ilonen, Karl B. Lemström, Juuso Paajanen, Olli Ritvos, Tommi Järvinen, Hely Ollila
Publikováno v:
Clinical lung cancer. 21(3)
Activin A has previously been associated with cancer cachexia and in vitro resistance to platinum-based chemotherapy. We studied circulating activin A concentrations as well as activin B and their antagonists' follistatin/follistatin-like 3 in presur
Autor:
Hannu Kankaanranta, Eija-Riitta Salomaa, Katri Koli, Riitta Kaarteenaho, Ulla Hodgson, Tero Vahlberg, Jaana Kaunisto, Marjukka Myllärniemi
Publikováno v:
ERJ Open Research, Vol 5, Iss 3 (2019)
ERJ Open Research
ERJ Open Research
Idiopathic pulmonary fibrosis (IPF) is characterised by unpredictable disease course and poor survival. After the introduction of novel antifibrotic drugs, the prognosis of patients with IPF is probably changing. FinnishIPF, a nationwide registry of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::408a496a8e3bb18ddd93fa7a7bd83a51
http://hdl.handle.net/10138/313003
http://hdl.handle.net/10138/313003